A pan tumor clinical trial allows for multiple cancers to be treated within the same clinical trial.
You may have heard of these trials referred to as multi-tumor or basket trials. The purpose is to help accelerate the development of potential research options for patients with both commonly known and understudied cancers. This approach provides a faster way to assess safety and the effectiveness of experimental medications by analyzing unique biomarkers (an indicator in the body) that may indicate a response to the study drugs. This gives potential patients with different tumor types an opportunity to enroll into a clinical trial and receive research treatment options such as immunotherapy.
Patients diagnosed with solid tumors (a tumor that does not contain a cyst or liquid) and/or hematologic malignancies (blood cancer) may be eligible for pan tumor clinical trials.